Metraipolis › archive › dc_ed729bc884d1
Case Report: Palopegteriparatide as a novel therapeutic option in pediatric autosomal dominant hypocalcemia type 1 — Europe PMC PMID:42388864
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42388864
- DOI
- 10.3389/fendo.2026.1837966
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T10:04:15.287Z
- SHA-256 of the archived text
b7f853a57240a9fbe1029265ae22acc0cf608cc13bf2aa60936afa8125110169- Stable URL of this page
https://metraipolis.com/documento/dc_ed729bc884d1
How to cite
Case Report: Palopegteriparatide as a novel therapeutic option in pediatric autosomal dominant hypocalcemia type 1 — Europe PMC PMID:42388864 — Europe PMC (en), https://europepmc.org/article/MED/42388864 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed729bc884d1 (Metraipolis archive dc_ed729bc884d1, sha256 b7f853a57240a9fbe1029265ae22acc0cf608cc13bf2aa60936afa8125110169)
BibTeX
@misc{dced729bc884d1,
title = {Case Report: Palopegteriparatide as a novel therapeutic option in pediatric autosomal dominant hypocalcemia type 1 — Europe PMC PMID:42388864},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42388864},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed729bc884d1; sha256 b7f853a57240a9fbe1029265ae22acc0cf608cc13bf2aa60936afa8125110169},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42388864. Agents can read the archived copy with the MCP tool read_document.